Stoke Therapeutics, Inc.
STOK$528M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBEDFORD128 employees
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Mar 15, 2027
49wMarket Overview
Stock performance and key metrics
STOK News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
zorevunersen
Dravet Syndrome
STK-001 - Single Ascending Doses
Dravet Syndrome
STK-001
Dravet Syndrome
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
zorevunersen | Phase 3 | Dravet Syndrome | - | - |
STK-001 - Single Ascending Doses | Phase 2 | Dravet Syndrome | - | - |
STK-001 | Phase 2 | Dravet Syndrome | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply